Mississippi Governor Vetoes Medical Cannabis Expansion Bills
Mississippi medical cannabis program challenges continue as the governor vetoes bills expanding access. This policy decision impacts patient care and clinical decision-making. Meanwhile, psychedelic research initiatives advance, creating a complex…
Clinical Implications of Real-World Evidence from the CARE Study [Response to Letter]
Clinical implications real world evidence from the CARE study provide valuable insights into medical cannabis outcomes. This research bridges gaps left by controlled trials by capturing diverse patient experiences. Understanding this evidence helps…
Second Time’s a Charm for Omnibus Cannabis Bill
The omnibus cannabis bill session daily highlights significant legislative reform affecting medical cannabis access and regulation. This bill impacts patient access, provider guidelines, and regulatory frameworks. Clinicians and patients should monitor…
Idaho Medical Marijuana Campaign Highlights Access Barriers and Economic Impact
Idaho medical cannabis access barriers remain significant due to restrictive state laws. The legalization ballot measure could generate substantial economic activity while improving patient access. Understanding these barriers is crucial for advancing…
Auxly Reports Fourth Quarter and Full Year 2025 Results
Cannabis companies ended 2025 with weakening financial positions, affecting supply chain reliability and patient access to medical cannabis products. Auxly's financial results reflect broader market conditions impacting licensed producers. Monitoring…
Cannabis Stocks To Research – March 26th | MarketBeat
This article covers cannabis stocks research March 26th MarketBeat with a focus on clinical evidence and patient safety. It highlights the distinction between financial market trends and medical cannabis treatment. Clinicians should rely on clinical data…
NM Republican Candidate Discusses Healthcare and Cannabis Policy
This article highlights political healthcare cannabis policy and its impact on patient access. Understanding these policies is crucial for clinicians preparing for regulatory changes. The NM Republican candidate's positions may influence medical cannabis…
2 Reasons to Like THC and 1 to Stay Skeptical – The Globe and Mail
This clinical summary THC holdings clarifies the difference between financial market analysis and medical cannabis research. Patients often confuse investment news with clinical evidence. Clinicians should guide patients to focus on peer-reviewed studies…
Virginia Cannabis Business Registration Progresses | Local News
Virginia adult-use cannabis registration is moving forward, marking a significant step in regulated cannabis markets. This progress enhances patient access to consistent, tested cannabis products. Clinicians can expect improved product standardization…
Federal Policy Allows States to Self-Regulate Cannabis: New Report Insights
State cannabis regulatory variation creates significant challenges for clinical care. Differences in testing and potency standards impact patient safety and treatment continuity. Understanding these variations is essential for effective medical cannabis…